Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

GARS antibody (AA 567-735)

GARS Reactivity: Human WB, IHC, IP, ICC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN1868113
  • Target See all GARS Antibodies
    GARS (Glycyl-tRNA Synthetase (GARS))
    Binding Specificity
    • 6
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 567-735
    Reactivity
    • 51
    • 17
    • 16
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 40
    • 11
    Rabbit
    Clonality
    • 35
    • 16
    Polyclonal
    Conjugate
    • 30
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    This GARS antibody is un-conjugated
    Application
    • 28
    • 14
    • 9
    • 8
    • 7
    • 7
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Purpose
    Polyclonal Antibody to Glycyl tRNA Synthetase (GARS)
    Specificity
    The antibody is a rabbit polyclonal antibody raised against GARS. It has been selected for its ability to recognize GARS in immunohistochemical staining and western blotting.
    Cross-Reactivity
    Mouse, Pig
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant Glycyl tRNA Synthetase (GARS) corresdonding to Val567~Glu735 with N-terminal His Tag
    Isotype
    IgG
    Top Product
    Discover our top product GARS Primary Antibody
  • Application Notes

    Western blotting: 0.5-2 μg/mL

    Immunohistochemistry: 5-20 μg/mL

    Immunocytochemistry: 5-20 μg/mL

    Optimal working dilutions must be determined by end user.

    Comment

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Preservative
    Sodium azide
    Precaution of Use
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Expiry Date
    24 months
  • Target
    GARS (Glycyl-tRNA Synthetase (GARS))
    Alternative Name
    Glycyl tRNA Synthetase (GARS Products)
    Synonyms
    CMT2D antibody, DSMAV antibody, GlyRS antibody, HMN5 antibody, SMAD1 antibody, Aat-gly antibody, CG6778 antibody, Dmel\\CG6778 antibody, GRS antibody, gars antibody, team antibody, RGD1559871 antibody, GENA202 antibody, Gena201 antibody, Nmf249 antibody, Sgrp23 antibody, GB13467 antibody, MGC79495 antibody, fb02f03 antibody, si:dkey-276i5.1 antibody, wu:fb02f03 antibody, NI36_08435 antibody, glycyl-tRNA synthetase antibody, Glycyl-tRNA synthetase antibody, glycine--tRNA ligase antibody, glycyl-tRNA synthetase L homeolog antibody, Glycine--tRNA ligase antibody, GARS antibody, GlyRS antibody, Gars antibody, LOC408392 antibody, gars.L antibody, gars antibody, LOC692991 antibody, glyQ antibody, TTHA0543 antibody, NI36_RS08405 antibody
    Background
    CMT2D, CMT2-D, DSMAV, GlyRS, SMAD1, EJ, Charcot-Marie-Tooth Neuropathy 2D, Glycine tRNA Ligase, Diadenosine tetraphosphate synthetase, AP-4-A synthetase
    Pathways
    Ribonucleoside Biosynthetic Process
You are here:
Support